Literature DB >> 35622254

Minimally Manipulated Bone Marrow-Derived Cells Can Be Used for Tissue Engineering In Situ and Simultaneous Formation of Personalized Tissue Models.

D S Baranovskii1,2, B G Akhmedov3, A G Demchenko4, M E Krasheninnikov2, M V Balyasin2, O Yu Pavlova5, N S Serova5, O A Krasil'nikova1, P V Shegai1, A D Kaprin1,2, I D Klabukov6.   

Abstract

Red bone marrow and autologous bone tissue (bone fragments and bone chips) of the donor were harvested intraoperatively during autoplasty of talus bone defect. Titanium chips were obtained by grinding a fragment of a microporous titanium-coated hip arthroplasty (Zimmer). Bone marrow mononuclear cells were isolated in the operating room, and bone and titanium fragments were incubated with a suspension of mononuclear cells. The quality of revitalization was assessed by fluorescence microscopy and histological examination after culturing of adherent cells on the bone and titanium fragments. During culturing on bone chips, bone marrow mononuclear fraction cells demonstrated significantly higher metabolic activity than bone marrow cells (p=0.04). Mononuclear fraction cells were also capable of stable colonization of titanium fragments with the formation of composite tissue model.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  bone marrow mononuclear cells; bone regeneration; in situ; tissue engineering; tissue models

Mesh:

Substances:

Year:  2022        PMID: 35622254     DOI: 10.1007/s10517-022-05509-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  17 in total

1.  The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.

Authors:  Qiang Mao; Hongting Jin; Fei Liao; Luwei Xiao; Di Chen; Peijian Tong
Journal:  Bone       Date:  2013-08-29       Impact factor: 4.398

2.  Autologous Bone Marrow-Derived Mononuclear Cells Combined With β-TCP for Maxillary Bone Augmentation in Implantation Procedures.

Authors:  Dmitry Bulgin; Enes Hodzic
Journal:  J Craniofac Surg       Date:  2017-11       Impact factor: 1.046

3.  The new legal framework for minimally manipulated cells expands the possibilities for cell therapy in Russia.

Authors:  Olga A Krasilnikova; Ilya D Klabukov; Denis S Baranovskii; Peter V Shegay; Andrey D Kaprin
Journal:  Cytotherapy       Date:  2021-05-10       Impact factor: 5.414

Review 4.  Strategies of enhancing bone regenerate formation in distraction osteogenesis.

Authors:  Mohammad Mesfer Alzahrani; Emad Anam; Saad M AlQahtani; Asim M Makhdom; Reggie C Hamdy
Journal:  Connect Tissue Res       Date:  2017-03-08       Impact factor: 3.417

5.  Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche.

Authors:  E Birmingham; G L Niebur; P E McHugh; G Shaw; F P Barry; L M McNamara
Journal:  Eur Cell Mater       Date:  2012-01-12       Impact factor: 3.942

Review 6.  Autograft, Allograft, and Bone Graft Substitutes: Clinical Evidence and Indications for Use in the Setting of Orthopaedic Trauma Surgery.

Authors:  Paul Baldwin; Deborah J Li; Darryl A Auston; Hassan S Mir; Richard S Yoon; Kenneth J Koval
Journal:  J Orthop Trauma       Date:  2019-04       Impact factor: 2.512

7.  Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation.

Authors:  Sandro Giannini; Roberto Buda; Marco Cavallo; Alberto Ruffilli; Annarita Cenacchi; Carola Cavallo; Francesca Vannini
Journal:  Injury       Date:  2010-10-08       Impact factor: 2.586

8.  Allograft alone versus allograft with bone marrow concentrate for the healing of the instrumented posterolateral lumbar fusion.

Authors:  Radek Hart; Martin Komzák; František Okál; David Náhlík; Pavel Jajtner; Miloš Puskeiler
Journal:  Spine J       Date:  2013-12-20       Impact factor: 4.166

9.  Bone marrow aspirate concentrate and platelet-rich plasma enhanced bone healing in distraction osteogenesis of the tibia.

Authors:  Dong Hoon Lee; Keun Jung Ryu; Jin Woo Kim; Kyung Chung Kang; Young Rak Choi
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

10.  Determination of the effective dose of bone marrow mononuclear cell therapy for bone healing in vivo.

Authors:  Maren Janko; Sabrina Pöllinger; Alexander Schaible; Marlene Bellen; Katrin Schröder; Myriam Heilani; Charlotte Fremdling; Ingo Marzi; Christoph Nau; Dirk Henrich; René D Verboket
Journal:  Eur J Trauma Emerg Surg       Date:  2020-02-28       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.